The Discounted Cash Flow (DCF) valuation of Iovance Biotherapeutics Inc (IOVA) is (51.00) USD. With the latest stock price at 1.76 USD, the upside of Iovance Biotherapeutics Inc based on DCF is -2997.8%.
Based on the latest price of 1.76 USD and our DCF valuation, Iovance Biotherapeutics Inc (IOVA) is a sell. selling IOVA stocks now will result in a potential gain of 2997.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.7% - 9.4% | 8.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (112.12) - (34.83) | (51.00) |
| Upside | -6470.4% - -2078.8% | -2997.8% |